Revolution Medicines, Inc. (RVMD) Misses Q3 EPS by 20c
Tweet
Share
E-mailGet Alerts RVMD Hot Sheet
Join SI Premium – FREE
Revolution Medicines, Inc. (NASDAQ: RVMD) reported Q3 EPS of ($1.61), $0.20 worse than the analyst estimate of ($1.41). Revenue for the quarter came in at $0 versus the consensus estimate of $1.95 million.
For earnings history and earnings-related data on Revolution Medicines, Inc. (RVMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sprinklr (CXM) Tops Q2 EPS by 1c, Offers Guidance
- Contango Silver & Gold reports high-grade gold hits at Lucky Shot
- Sensata launches R290 pressure and temperature sensor for EV systems
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
